Lemsip Max Blackcurrant Flavour tablets

Land: Storbritannien

Språk: engelska

Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiva substanser:

Paracetamol; Phenylephrine hydrochloride

Tillgänglig från:

Reckitt Benckiser Healthcare (UK) Ltd

INN (International namn):

Paracetamol; Phenylephrine hydrochloride

Dos:

500mg ; 6.1mg

Läkemedelsform:

Oral tablet

Administreringssätt:

Oral

Klass:

No Controlled Drug Status

Receptbelagda typ:

Valid as a prescribable product

Produktsammanfattning:

BNF: 04070100; GTIN: 5000158068377

Produktens egenskaper

OBJECT 1
LEMSIP MAX BLACKCURRANT FLAVOUR
TABLETS
Summary of Product Characteristics Updated 16-Jan-2014 | Reckitt
Benckiser Healthcare (UK) Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Lemsip Max Blackcurrant Flavour Tablets
2. Qualitative and quantitative composition
Each tablet contains 500 mg of paracetamol and 6.10 mg of
phenylephrine hydrochloride.
Excipients:
Each tablet contains 40 mg of aspartame.
For a full list of excipients, see Section 6.1.
3. Pharmaceutical form
Tablet.
A convex pale purple oval shaped tablet with blackcurrant odour.
4. Clinical particulars
4.1 Therapeutic indications
For relief of symptoms of colds and influenza, including the relief of
aches and pains, sore throat,
headache, nasal congestion and lowering of temperature.
4.2 Posology and method of administration
Adults (16 years and over): Two tablets every 4-6 hours to a maximum
of four doses in any 24 hours.
Do not exceed eight tablets in any 24 hours.
Children 12-15 years: One tablet every 4